Via Christi Hospital in Wichita is one of the Midwest's leading sites for advanced clinical research. Via Christi's strong research program attracts world-class physicians and other professionals and supports medical education. Most of all, it provides early access to advanced therapies for patients.
Via Christi Research manages studies in these therapeutic areas:
- Cardiovascular Disease
- Infectious Disease
- Smoking Cessation
- Surgical Interventions
Although clinical studies occur in many locations, for many specialties and by various investigators, all research conducted at the hospital must be submitted to its institutional review board. In the face of increasing regulations around human subject research, Via Christi is committed to maintaining the highest standards to protect participants.
Via Christi Research, Inc., has conducted more than 150 pharmaceutical and medical device trials for more than 40 national and international clients since 1988. The company manages studies in the therapeutic areas of psychiatry, cardiovascular disease, neurology, infectious disease, smoking cessation, anesthesiology, surgical interventions and endocrinology. It maintains a 24-bed Phase I dedicated research facility at Via Christi Hospital on St. Francis. Via Christi Research is a not-for-profit organization that invests excess revenues in research studies not funded by commercial sponsors, such as the management of diabetes and childhood obesity. In 2004 it became one of the nation's few clinical research institutes to achieve ISO 9001-2000 certification – a prestigious, internationally recognized standard of quality.
Patients and healthy people have the opportunity to enroll in investigational treatment and early detection/prevention studies through the Wichita Clinical Community Oncology Program (WCCOP). Based at Via Christi Hospital on St. Francis, WCCOP is sponsored and funded by the National Cancer Institute and participates in research protocols developed by the Southwest Oncology Group, North Central Cancer Treatment Group (Mayo Clinic), M.D. Anderson Cancer Center, National Surgical Adjuvant Breast and Bowel Project, Children's Oncology Group and the University of Rochester (N.Y.) Cancer Center. About 190 trials are currently open. Wichita's CCOP has received national recognition for its effective methods of patient recruitment and physician support.
Via Christi Comprehensive Epilepsy Center is the site of several local and national research studies including an ongoing investigation of brain cooling during epilepsy surgery, clinical trials of new epilepsy drugs and others.
The Orthopaedic Research Institute is devoted to applied research and development in support of orthopaedics and other medical specialties. The institute has a strong emphasis in the design, development and testing of orthopedic implants, surgical instruments, and related hardware and software systems.
Via Christi Research was established in 1988 as Psychiatric Research Institute, later to be known as PriVia, the Research Centers of Via Christi. In 2007, Via Christi Research became a department of Via Christi Regional Medical Center, now known as Via Christi Hospital in Wichita, and thus had become part of the largest health care provider in Kansas.
Located in Wichita, the largest city in the state, Via Christi Research works with many world-class physicians to provide cutting-edge treatment in the areas of anesthesiology, cardiovascular disease, critical care, cystic fibrosis, dementia, diabetes, epilepsy, gastroenterology, HIV, infectious disease, neurology, orthopedics, psychiatry, surgical interventions and trauma to patients who would not otherwise have access to clinical trials. With 20 years of experience in all phases (I-IV) of clinical trials with both pharmaceuticals and medical devices, Via Christi Research is a proven leader.